Grup d'estudis moleculars del càncer i dels efectes de les radiacions ionitzants (RADiCAN)

Keyphrases

1. Interlaboratory Comparison 100%
2. RENEB 80%
3. Biological Dosimetry 68%
4. Dose Estimates 52%
5. Dose Estimation 50%
6. Ionizing Radiation 45%
7. γH2AX Foci 45%
8. Calibration Curve 44%
9. Clinically Significant 39%
10. Genetic Variants 35%
11. Dicentric Chromosome Assay 35%
12. Irradiation 32%
13. Peripheral Blood Mononuclear Cells 31%
14. Dicentric Assay 28%
15. Radiation Exposure 27%
16. X-ray 27%
17. Blood Samples 27%
18. Assay Comparison 26%
19. Ionizing Radiation Effects 26%
20. Radiation Dose Assessment 26%
21. Manual Scoring 25%
22. Neutron 23%
23. R Shiny Application 23%
24. Exposure Uncertainty 23%
25. Estimation Process 23%
26. Intercomparison Exercise 23%
27. Irradiation Facility 23%
28. International Comparison 23%
29. Plasma Focus Device 23%
30. Ray Effect 23%
31. Childhood Leukemia 23%
32. Radiation Indicator 23%
33. Health Indicators 23%
34. Highly Exposed 23%
35. Chromosomal Aberrations 23%
36. TP53 Gene 23%
37. Therapy-related Myeloid Neoplasms 23%
38. Peripheral Blood Lymphocytes 23%
39. MDM2 Gene 23%
40. Well-being 23%
41. Cell Subtypes 23%
42. Resilience 23%
43. Gold Nanoparticles 23%
44. Dosimetry 23%
45. Molecular Biomarkers 23%
46. Mobile Phone Application 23%
47. In Cancer 23%
48. Prognostic Biomarker 23%
49. H2AX 23%
50. Radiosensitizing Effect 23%
51. Nuclear Accident 23%
52. Cancer Cell Lines 23%
53. Assessment Method 23%
54. Physical Retrospective Dosimetry 23%
55. Radiological Accident 21%
56. Overdispersion 21%
57. Clinical Decision-making 20%
58. Triage 19%
59. Radiation Dose 19%
60. Reference Dose 19%
61. Dicentric Chromosome 19%
62. Semi-automatic 17%
63. Post-irradiation 17%
64. Irradiation Time 17%
65. Bayesian Methods 16%
66. European Network 16%
67. Electron Paramagnetic Resonance 15%
68. Irradiated Sample 14%
69. Biological Efficacy 14%
70. Nuclear Events 12%
71. Physical Dosimetry 12%
72. Childhood Cancer 11%
73. Chemotherapy Agents 11%
74. Therapy-Related Tumors 11%
75. Acute Lymphoblastic Leukemia 11%
76. Therapeutic Radiation 11%
77. High Risk 11%
78. Patient Survival 11%
79. Apoptosis 11%
80. Resistance to Chemotherapy 11%
81. Programmed Cell Death 11%
82. Germline Genetic Variant 11%
83. Cancer Monitoring 11%
84. Surveillance-response 11%
85. Cancer Cells 11%
86. Agent-based 11%
87. Aggressive Therapy 11%
88. Treatment Personalization 11%
89. Accident Recovery 11%
90. Stakeholder Awareness 11%
91. Total Ionizing Dose 11%
92. Readiness Level 11%
93. Cutout 11%
94. Approximation Methods 11%
95. Somatic Genetics 11%
96. Detection Technology 11%
97. Cancer Risk Assessment 11%
98. Patient Outcomes 11%
99. Genetic mutation 11%
100. Radiation Biomarkers 11%